Ftse Mib
34.603,61
-0,64%
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.232,45
0,14%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Ambrx Biopharma Inc (AMAM) Ambrx Biopharma Inc (AMAM) Notizie

AMAM

Ambrx Biopharma (AMAM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:AMAM
DataOraFonteTitoloSimboloCompagnia
12/10/202322:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202312:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
10/10/202317:35Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AMAMAmbrx Biopharma Inc
07/07/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMAMAmbrx Biopharma Inc
28/06/202322:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
28/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
25/05/202322:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:AMAMAmbrx Biopharma Inc
18/05/202322:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:AMAMAmbrx Biopharma Inc
16/05/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:AMAMAmbrx Biopharma Inc
11/05/202322:08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:AMAMAmbrx Biopharma Inc
05/05/202322:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:AMAMAmbrx Biopharma Inc
28/04/202322:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:AMAMAmbrx Biopharma Inc
28/04/202322:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:AMAMAmbrx Biopharma Inc
27/04/202322:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:AMAMAmbrx Biopharma Inc
18/04/202322:16Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:AMAMAmbrx Biopharma Inc
03/04/202312:18Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NYSE:AMAMAmbrx Biopharma Inc
30/03/202323:23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NYSE:AMAMAmbrx Biopharma Inc
30/03/202322:10Edgar (US Regulatory)Annual Report (10-k)NYSE:AMAMAmbrx Biopharma Inc
16/03/202322:14Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NYSE:AMAMAmbrx Biopharma Inc
16/03/202321:37Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NYSE:AMAMAmbrx Biopharma Inc
16/03/202321:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:AMAMAmbrx Biopharma Inc
16/03/202321:07Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NYSE:AMAMAmbrx Biopharma Inc
16/12/202223:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:AMAMAmbrx Biopharma Inc
11/12/202218:37TipRanksMeet the Biotech Stock That Jumped Over 1000% in One DayNYSE:AMAMAmbrx Biopharma Inc
11/12/202218:25TipRanksCowen & Co. Keeps Their Buy Rating on Ambrx Biopharma (AMAM)NYSE:AMAMAmbrx Biopharma Inc
09/12/202216:36TipRanksAMAM Pops After Positive Clinical Trial DataNYSE:AMAMAmbrx Biopharma Inc
09/11/202214:00Business WireAmbrx Announces NovoCodex’s Dosing of First Patient with ARX305, Ambrx’s Investigational Antibody Drug Conjugate Targeting CD70NYSE:AMAMAmbrx Biopharma Inc
01/11/202221:05Business WireAmbrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive OfficerNYSE:AMAMAmbrx Biopharma Inc
18/10/202222:05GlobeNewswire Inc.Ambrx Biopharma Inc. Announces Strategic Reprioritization and Provides Corporate UpdateNYSE:AMAMAmbrx Biopharma Inc
11/10/202222:05GlobeNewswire Inc.Ambrx Biopharma to Host Corporate Update Conference CallNYSE:AMAMAmbrx Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:AMAM

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network